CD40 expressed on human melanoma cells mediates T cell co-stimulation and tumor cell growth

International Immunology

Volumn 12, Issue 6, 2000, Pages 787-795

  Pirozzi, Giuseppe ^a   Lombari, Vincenza ^a   Zanzi, Delia ^b   Ionna, Franco ^a   Lombardi, Maria Luisa ^a   Errico, Simona ^a   Ruggiero, Giuseppina ^b   Manzo, Ciro ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

CD40; Cell growth; Co stimulation; Melanoma

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GROWTH FACTOR RECEPTOR; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA CELL; METASTASIS; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0034124140     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/12.6.787     Document Type: Article

References (59)

1. Janeway, C. J. and Bottombly, K. 1994. Signals and signs for lymphocyte responses. Cell 71:1065.
2. Lenschow, D. J., Walunas, T. L. and Bluestone, J. A. 1996. CD28/ B7 system of T cell co-stimulation. Annu. Rev. Immunol. 14:233.
3. Johnson, J. G. and Jenkins, M. K. 1994. Monocytes provide a novel co-stimulatory signal to T cells that is not mediated by the CD28/B7 interaction. J. Immunol. 152:429.
4. Shahinian, A., Pfeffer, K., Lee, K. P., Kunding, T. M., Kishihara K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B. and Mak, T. W. 1993. Differential T cell co-stimulatory requirements in CD28-deficient mice. Science 261:609.
5. Agemattsu, K., Kobata, T., Sugita, K., Freeman, G. J., Beckmann M. P., Schlossman, S. F. and Morimoto, C. 1994. Role of CD27 in T cell immune response. J. Immunol. 153:1421.
6. + T lymphocytes. J. Immunol. 152:1523.
7. Hintzen, R. Q., de Jong, R., Lens, S. M. A. and van Lier, R. A. W. 1994. CD27: marker and mediator of T-cell activation? Immunol. Today 15:307.
8. Hurban, J. L. and Schreiber, H. 1992. Tumor antigens. Annu. Rev. Immunol. 10:617.
9. Boon, T., Cerottini, J. C., Van den Eynde, B., van der Bruggen, P. and Van Pel, A. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12:337.
10. Chen, L., Linsley, P. S. and Helleström, K. E. 1993. Co-stimulation of T cells for tumor immunity. Immunol. Today 14:482.
11. Clark, E. A. 1990. CD40: a cytokine receptor in search of a ligand. Tissue Antigens 36:33.
12. Schiever, F., Freeman, A. S., Freeman, G., Messner, E., Lee, D., Daley, J. and Nadler, L. M. 1989. Isolated human dendritic cells display a unique antigenic phenotype. J. Exp. Med. 169:2043.
13. Alderson, M. R., Armitage, R. J., Tough, T. W., Strockbine, L., Fanslow, W. C. and Spriggs, M. K. 1993. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178:669.
14. Durie, F. H., Foy, T. M., Masters, S. R., Laman, J. D. and Noelle, R. J. 1994. The expanding role of CD40 in the regulation of humoral, cell-mediated immunity and T cell education. Immunol. Today 15:406.
15. Smith, C. A., Farrah, T. and Goodwin, G. R. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, co-stimulation and death. Cell 76:959.
16. Camerini, D., Walz, G., Loenen, V. A. M., Borst, J. and Seed, B. 1991. The T cell activation antigen CD27 is a member of the NGF/TNF receptor gene family. J. Immunol. 147:3165.
17. Dürkop, H. J., Latza, U., Hummel, M., Eitelbach, F., Sead, B. and Stein, H. 1992. Molecular cloning and expression of a new member of nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 65:421.
18. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y. and Nagata, S. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233.
19. Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. M., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewki, C. R., Clark, E. A., Smith, C. A., Grabein, K. H., Cosman, D. and Spriggs, M. K. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature 357:80.
20. Hollenbough, D., Grosmaire, L. S., Kullas, C. D., Chalupny, N. J., Braesch-Anderson, S., Noelle, R. J., Stamenkowic, I., Ledbetter, J. A. and Aruffo, A. 1992. The human antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of the gp39 with B cell co-stimulatory activity. EMBO J. 11:4313.
21. Gauchat, J. F., Henchoz, S., Mazzei, G., Aubry, J. P., Brunner, T., Blasey, H., Life, P., Talabot, D., Flores-Romo, L., Thompson, J., Kinshi, K., Butterfield, J., Dahinden, C. and Bonnefoy, J. Y. 1993. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365:340.
22. Gauchat, J. F., Henchoz, S., Fattah, D., Mazzei, G., Aubry, J. P., Jamotte, T., Dash, L., Page, K., Solari, R., Aldebert, M., Capron, D., Dahinden, C. and Bonnefoy, J. Y. 1995. CD40 ligand functionally expressed on human eosinophils. Eur. J. Immunol. 25:863.
23. Grammer, A., Bergman, M. C., Miura, Y., Fujita, K., Davis, L. S. and Lipsky, P. E. 1995. The CD40 ligand expressed by human B cells co-stimulates B cell responses. J. Immunol. 23:943.
24. Callard, R. E., Armitage, R. J., Fanlow, W. C. and Spriggs, M. K. 1993. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol. Today 14:559.
25. Foy, T. M., Page, D. M., Waldschmidth, T. J., Schoneveld, A., Laman, J. D., Masters, S. R., Tygrett, L., Ledbetter, J. A., Aruffo, A., Claasen, E., Xu, J. C., Flavell, R. A., Oehen, S., Hedrick, S. M. and Noelle, R. J. 1995. An essential role of gp39, the ligand of CD40, in thymic selection. J. Exp. Med. 182:1377.
26. Ruggiero, G., Martinez Cacères, E., Voordouw, A., Noteboom, E., Graf, D., Kroczek, R. A. and Spits, H. 1996. CD40 expressed on thymic epithelial cells provides co-stimulation for proliferation but not for apoptosis of human thymocytes. J. Immunol. 156:3737.
27. Grewal, I. S., Xu, J. and Flavell, R. A. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378,617.
28. van Essen, D., Kikutani, H. and Gray, D. 1995. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378:620.
29. Galy, A. and Spits, H. 1992. CD40 functionally expressed on human thymic epithelial cells. J. Immunol. 149:775.
30. Denfeled, R. W., Hollenbaugh, D., Fehrenbach, A., Weiss, J. M., von Leoprechting, A., Mai, B., Voith, U., Schopf, E., Aruffo, A. and Simon, J. C. 1996. CD40 is functionally expressed on human keratinocytes. Eur. J. Immunol. 26:2329.
31. Fries, K. M., Sempowski, G. D., Gaspari, A. A., Blienden, T., Looney, R. J. and Phipps, R. P. 1995. CD40 expression by human fibroblasts. Clin. Immunol. Immunopathol. 77:42.
32. Hollenbaugh, D., Mischel-Petty, N., Edwards, C. P., Simon, J. C., Denfeld, R. W., Kiener, P. A. and Aruffo, A. 1995. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182:33.
33. Zong, Y. S., Lin, H., Choy, D. T. K., Sham, J. S. T., Wie, W., Chang, K. H. and Ng, M. H. 1991. Nasopharingeal carcinoma and lymphoinfiltration. Oncology 48:290.
34. Paulie, S., Ehlin-Herriksson, B., Mellstedt, H., Koho, H., Ben-Aissa, H. and Perlmann, P. 1985. A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol. Immunother. 20:23.
35. Jakobson, E., Jonsson, G., Bjorck, P. and Paulie, S. 1998. Stimulation of CD40 in human bladder carcinoma cells inhibit anti-Fas/APO-1 (CD95)-induced apoptosis. Int. J. Cancer 77:849.
36. Wingett, D. J., Vestal, R. E., Forcier, K., Hadjokas, N. and Nielson, C. P. 1998. CD40 is functionally expressed on human breast carcinomas: variable inducibility by cytokines and enhancement of Fas-mediated apoptosis. Breast Cancer Res. Treat. 50:27.
37. Thomas, W. D., Smith, M. J., Si, Z. and Mersey, P. 1996. Expression of the co-stimulatory molecule CD40 on melanoma cells. Int. J. Cancer 68:795.
38. von Leoprechting, A., van der Bruggen, P., Pahl, H. L., Aruffo, A. and Simon, J. C. 1999. Stimulation of CD40 on immunogeneic human malignant melanomas augments their cytotoxic T lymphocyte-mediated lysis and induces apoptosis. Cancer Res. 59:1287.
39. Rosenberg, S. A., Yannelli, J. Y. and Yang, J. C. 1994. Treatment of patients with metastatic melanoma using autologous tumor-infiltrating lymphocytes and Interleukin-2. J. Natl. Cancer Inst. 86:1159.
40. Ferrone, S. 1994. Melanoma, immune surveillance, and immunotherapy. J. Clin. Invest. 93:1351.
41. De Waard-Siebinga, I., Blom, D. J., Griffioen, M., Schrier, P. I., Hoogendoorn, E., Beverstock, G., Danen, E. H. and Jager, M. J. 1995. Establishment and characterization of an uveal-melanoma cell line. Int. J. Cancer 62:155.
42. Azuma, M., Cayabyan, M., Buck, J. H., Phillips, J. H. and Lanier, L. L. 1992. Interaction with B7 co-stimulate primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med. 175:373.
43. Van Lier, R. A. W., Boot, J. H., De Groot, E. R. and Aarden, L. A. 1987. Induction of T cell proliferation with anti-CD3 switch-variant monoclonal antibodies: effect of heavy chain isotype in monocyte-dependent systems. Eur. J. Immunol. 17:1599.
44. Lens, S. M. A., Tesselaar, K., den Drijver, B. F. A., van Oers, M. H. J. and van Lier, R. A. W. 1996. A dual role for both CD40-ligand and TNF-α in controlling human B cell death. J. Immunol. 156:507
45. Lanier, L. L. and Recktenweld, D. J. 1991. Multicolor immunofluorescence and flow cytometry. Methods Compan. Methods Enzymol. 2:192.
46. Noelle, R. J. 1996. CD40 and its ligand in host defense. Immunity. 4:415.
47. Yellin, M. J., Winikoff, S., Fortune, S. M., Baum, D., Crow, M. K., Lederman, S. and Chess, L. 1995. Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation, IL-6 production and proliferation. J. Leuk. Biol. 58:209.
48. Ranheim, E. A. and Kipps, T. J. 1993. Activated T cells induce expression of B7/BB1 in normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:925.
49. Van Kooten, C. and Banchereau, J. 1997. Functions of CD40 on B cells, dendritic cells and other cells. Curr. Opin. Immunol. 9:330.
50. Grewal, I. S. and Flavell, A. R. 1998. CD40 and CD154 in cell mediated immunity. Annu. Rev. Immunol. 16:111.
51. Damle, N. K., Klussman, K., Leytze, G. and Linsley, P. S. 1993. Proliferation of human T lymphocytes induced by superantigens is not dependent on co-stimulation by the counter-receptor B7. J. Immunol. 150:726.
52. + CTL response. J. Exp. Med. 183:2129.
53. Bennet, S. R. M., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. A. P. and Heath, W. R. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signaling. Nature 393:478.
54. Heemels, M. T. and Ploegh, H. 1995. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64:263.
55. Kageshita, T., Wang, Z., Calorini, L., Yoshii, A., Kimura, T., Ono, T., Gattoni-Celli, S. and Ferrone, S. 1993. Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens. Cancer Res. 53:3349.
56. Carbone, E., Ruggiero, G., Terrazzano, G., Palomba, C., Manzo, C., Fontana, S., Spits, H., Kärre, K. and Zappacosta, S. 1997. A new mechanism of NK cell cytotoxicily activation: the role of CD40-CD40 ligand interaction. J. Exp. Med. 185:2053.
57. Hess, S. and Engelmann, H. 1996 A novel function of CD40: induction of cell death in transformed cells. J. Exp. Med. 183:159.
58. Péguet-Navarro, J., Dalbiez-Gauthier, C., Moulon, C., Berthier, O., Réano, A., Gaucherand, M., Banchereau, J., Rousset, F. and Schmitt, D. 1997. CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation. J. Immunol. 158:144.
59. Anichini, A., Molla, A., Mortarini, R., Tragni, G., Bersani, I., Di Nicola, M., Gianni, M. A., Pilotti, S., Dunbar, R., Cerundolo, V. and Parmiani, G. 1999. An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions. J. Exp. Med. 190:651.